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INTRODUCTION
This Society—"devoted to the promotion of research in
science"—may very reasonably ask a speaker to begin his
address with a statement of the general or wider meaning of
current advances in the field for which he is to speak. Perhaps
the usefulness of such a general statement tonight is increased
by the circumstance that the present discussion concludes a
symposium of 10 lectures on Hormones which this Chapter of
Sigma Xi has been resourceful enough to arrange and present
within the year. Again, those several earlier and related dis-
cussions can very notably reinforce any general statement
which might be made concerning advances in the study of the
anterior pituitary hormones alone.
Almost too obvious to require mention in such a general
statement is the practical certainty that present and future
advances in our knowledge of the hormones will make medicine
more effective in dealing with at least several diseases and
incapacities of man and animals. But rightly notable here,
because rather less evident, are two somewhat related things:
First, some conditions not classifiable as disease but as sub-
normal developments of body or mind—such as small stature
and some forms of dull mentality—will probably prove more
amenable to favorable influence by hormones than from any
other therapeutic source. Second, the hormones have already
provided the essential basis for an understanding of the cycles
and reproductive adjustments peculiar to women, although 15
years ago not one of the several hormones involved in the pro-
duction of those cycles had been isolated or suitably measured.
Another 15 years should add very useful elements of control to
our present quite gratifying degree of comprehension of those
cyclical adjustments to which one-half of mankind is subjected
during much of the span of life.
Further—and this point is of interest to investigators in all
branches of science represented in this Society—advancing
knowledge of the hormones is enabling us to begin to see and
comprehend the mechanisms by which our own complex bodies
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maintain their own internal environment at a constant or steady
state. Moreover, some of these hormones have even shown
themselves to be the means by which certain peculiar aspects of
this steady internal state is sometimes greatly upset or changed
—likewise to the great advantage of the organism—and all this
supplies hitherto missing information on the great problems of
biologic organization and adaptation.
Precisely this last-named gain—a gain on a scientific and
philosophical question which has long seemed troublesome to
some scientific men—has such exceptionally wide application
in the sphere of thought that it deserves a central position in
this introductory statement. The knotty problems of adapta-
tion and complex animal organization—particularly that of the
brain and the regulatory processes of animals—have been
thought by some biologists and philosophers to be best accounted
for by the assumption of a guiding vitalistic force, a force
essentially divorced from matter and akin to the supernatural.
As the profound and peculiar regulatory powers of the hormones
have become even partly known—particularly since these
non-nervous chemical agents have been found to constitute an
additional regulatory mechanism affected by both the nervous
system and the external environment—the bases of the doctrine
of vitalism have been sapped and severely shaken. The newer
outlook conforms well with the naturalism so well stated by
Darwin in his great study of 1874. And we are encouraged to
proceed on the conception that an organism is to be understood,
if at all, in terms of its organization, its environment, and its
past. Up to now the supernatural has disclosed no sphere or
place of its own in organisms.
In calling attention to these broad or general contributions
of endocrinological research one should at once note that many
other branches of biological or life-science are making similar,
perhaps equal or greater, contributions to the present and
future well-being of man. Personally I like to think of the sum
of all this biological research as affording full justification for the
opinion and statement of a great mathematician and chemist
who for a generation was president of Harvard University and
perhaps America's greatest educational leader. Near the end
of his service at Harvard, President Charles W. felliot said:
'' The human race has more and greater benefits to expect from
the successful cultivation of the sciences which deal with living
things than from all the other sciences put together."
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Now lest some of my audience at once write me down as an
incurable optimist, supremely satisfied with all that is labelled
biological, I must add another general statement—and admis-
sion. It is this. Though our laboratories of endocrinology and
of a dozen other divisions of life-science have all done well
within their walls, they have failed in most of the world that
lies outside those walls. The thoroughly biological thing that
counts is man, the citizen—the walking, sleeping, or perhaps just
now, the "sit-down" citizen; and, the future citizens now in
public or other schools. These—our present and future cit-
izens—are now left largely untouched by the best products of
our biological laboratories. We learn; but we have established
only slender channels to the great stream of the mental life of
modern man. Within the time of men now alive we have
learned the broad outlines of man's own nature and man's place
in nature; but the citizen is unaware, and the future citizen
remains practically untaught. Our very best contributions are
to the mental orientation of men—yet any such contribution
whatever is contingent upon contact and possession and these
are not yet achieved. The laboratories have won only Pyrrhic
victories until secondary schools—the only broad path to our
people—begin the task of carrying basic biologic truth to our
future citizens.
From these very general and introductory reflections con-
cerning endocrinology and its biological settings we may next
turn to a consideration of some quite general aspects of present
knowledge of "the hormones of the anterior pituitary."
GENERAL CONSIDERATIONS
At this stage of high uncertainty concerning most that per-
tains to "anterior pituitary hormones" no one would elect to
speak or write on that subject. You are asked to understand
clearly that I have had no choice; I was drafted, and I am still
reluctant. There would be only pleasure in placing before you
such observations and measurements concerning some responses
to pituitary products as have been recently accomplished in our
own laboratory; but there is real danger that some opinions on
pituitary hormones which I am now forced to put on record will
be proved wrong even before the end of the present year. Our
actual knowledge of the hormones—the elaborated active mol-
ecules—of this remarkable gland is so fragmentary that even
our first words on the subject must include opinion and specula-
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tion. Sensing the harsh and speedy fate that awaits at least some
of the speculations which must be set down in the first section of
this communication I note that those paragraphs are to be
regarded as my own particular view of this subject on this
particular day.
To a highly significant degree the hormones of the anterior
pituitary have been found to exert their action upon other hor-
mone-producing organs. It now appears that the chief function
of the pituitary is to regulate the production of chemical reg-
ulators (hormones) in other endocrine glands. The effects of
pituitary hormones upon the several glands and processes of
the body are both numerous and impressive. Though these
effects or responses are as yet imperfectly known, and though
several known responses can not yet be definitely assigned to a
particular hormone, many responses have been and are now
being studied with notable success. As already suggested,
however, much less success has attended efforts to learn either
the true number or the chemical structure of the pituitary hor-
mones themselves. None of them has been isolated in a satis-
factorily pure state; and some of the imperfect isolations accom-
plished from dead pituitary tissue may represent only frag-
ments of those molecules (hormones) which pituitary cells
normally release from their surfaces. These uncertainties as to
the number and the chemical structure of A. P. hormones, like
the now recognized difficulties encountered in their isolation and
purification, are bound up with their probable protein (or
polypeptid) nature and with the further complicating circum-
stance that more than one hormone is produced in the gland;
indeed we are faced with a serious probability that more than
one hormone is produced by one and the same type of pituitary
cell, or even by the same cell.
While speaking of these uncertainties and probabilities we
may as well discuss a possible way of regarding the production
of a seeming multiplicity of hormones, or of hormone fragments,
from two types of secreting cells. Much cytological study of the
anterior pituitaries of higher vertebrates indicates the presence
there of three special types of cells—chromophobes, eosinophils
and basophils—and that only the two last-named types show
secretory activity. Again, studies of responses to pituitary
hormones or hormone-fragments, and also vague indications
obtained from methods of isolating these pituitary products,
provide some basis for grouping most or all of the secreted
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products into two groups. Thus the eosinophil cells would seem
to be the source of a prolactin-adrenotropin product; and this
substance probably elicits not only the responses already cred-
ited to these particular names, but also those responses desig-
nated as diabetogenic and ketogenic (and growth also in some
animals). The basophils would seem to be the source of follicle-
stimulating hormone (FSH) and probably for luteinizing and
such other gonadotropic hormones or hormone-fragments as
may exist (a gonadotropic contribution to the body growth of
some animals seems also probable). Whether the thyrotropic
hormone is of eosinophilic or of basophilic origin now seems only
a hazardous guess. But, besides its specific capacity to stimulate
the thyroid gland there is also reason to assign growth-promoting
capacity (in at least some animals) to this hormone. The con-
ception thus briefly stated requires further immediate comment.
On this view the writer does not find it necessary to allocate
a "growth " hormone to either type of cell, since he believes that
the unquestionable ability of the pituitary to promote bodily
growth really rests upon the aggregate of helpful things contrib-
uted by other (perhaps all) pituitary hormones. This view also
very definitely assigns to different pituitary hormones unequal
growth-promoting roles in different animal species—e. g.,
prolactin has been found of chief importance to growth in the
pigeon (1, 2); thyrotropic seems of chief importance in the
dwarf mouse (3); while no pituitary hormone is required for
continued normal growth in some of the lower vertebrates.
Again, removal of the pituitary gland (and all of its hormones)
in the young rat of 25-35 grams scarcely interferes with its
growth until after it reaches a weight of about 60 grams (4); and,
the same "growth" extract that will promote growth in normal
female rats from the 4th to 10th week of life will or may fail to
promote such growth in similar male rats (5). Sex difference as
well as species difference is concerned therefore in the growth
response of an animal to products of pituitary origin. Of course
Evans (6, 7, 8) long ago showed that adult male rats whose
growth curves have plateaued can be made to grow with alka-
line pituitary extracts. Finally, it is to be noted that in high
degree the pituitary hormones (or hormone fragments?) have
shown augmentation or synergistic actions upon each other;
and one such synergism of the growth response has been observed
(3) in the dwarf mouse and another on basal metabolic rate (2)—
with prolactin (or prolactin-adrenotropin) and thyrotropic
apparently here serving as members of the synergistic pair.
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It was indicated above that the product (or products) of
eosinophil cells yield many responses—those associated with
prolactin, adrenal repair, glycosuria, ketosis, and a r61e in
growth. The eosinophilic contribution to the growth response,
in most animals, probably exceeds that of the basophilic product.
Is more than one eosinophilic product liberated by the living
cell? Unless thyrotropic hormone, in addition to prolactin, is of
eosinophilic origin I do not think that present evidence compels
us to accept even a duality of normally liberated eosinophilic
products. Though there is non-negligible evidence for the
existence of an adrenotropic hormone, cortical repair—like
growth—may yet prove to be a response to other hormones,
even involving a synergistic action of these, and not a response
to a single entity. Again, it is perhaps conceivable that the
structure liberated by the eosinophil cell is a molecule holding
prolactin and adrenotropin in combination, and that this mole-
cule is split into parts by the means used for their seeming
(partial) isolation from the dead pituitary tissue (see below).
Certainly some fragmentary information, particularly that deal-
ing with pituitary influence on carbohydrate metabolism, sug-
gests a close association—perhaps interrelation is the better
word—of adrenal maintenance on the one hand with some of the
responses to prolactin on the other.
The basophilic product—a gonadotropic complex—is prob-
ably responsible for a specific stimulation of growth in gameto-
genic tissue and in interstitial tissues, besides inducing a trans-
formation (luteinization) of granulosa or of thecal cells of female
mammals into useful but fated luteal cells (or is the latter
process mediated by products originating in adrenals, gonads,
etc.?). The number of hormones, or of hormone fragments,
involved in regulating these responses is not clear. The status
of FSH as a definite normally released product of the pituitary
is conceded by all investigators. The almost complete separation
of two fractions having gametogenic (FSH) and luteinizing
(LH) properties has been reported by Fevold, Hisaw et al (9)
and Wallen-Lawrence (10). Evans et al (11) report still other
active fractions; and Smith, Engle and Tyndale (12) report
fairly complete separation of one principle (LH) from pregnancy
urine and another (FSH) from castrate and menopausal urine.
Since pituitary hormones—not responses to pituitary prod-
ucts—are the subject of this paper we must further pursue these
considerations. Not only may our extraction methods pick up
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unfinished hormone fragments from the interior of dead pituitary
cells; these methods—in addition to their known capacity to
inactivate (more or less rapidly) the true hormones themselves—
are perhaps also capable of both physically separating and of
chemically changing two or more of the fragments that should
form a molecule of a true hormone. It is improbable, though
conceivable, that some apparant synergisms among pituitary
products may rest therefore upon the chance given such frag-
ments to recombine (when later put simultaneously in the
blood stream) and form more of the true hormone. On a priori
grounds there is a fair probability that some of these fragments
of hormones have physiological activity, but physiological
activity that is not identical with that of the entire molecule
(hormone) which is normally liberated by the living pituitary
cell. If this is true, our pituitary "extracts" contain a greater
number of active products than of products to which the name
hormone properly applies.
From what has just been stated it is clear that some impor-
tance attaches to the fact that certain pituitary hormones have
been recovered from the blood. Though present failure to find
certain pituitary products in the blood stream does not declare
that such products are not normally liberated from the secreting
pituitary cells—and therefore not true hormones—the short list
of hormones that have been so recovered deserves mention.
Prolactin has been reported in post-partum human serum
by Tesauro (13); our laboratory has detected it in the serum of
pregnant mares, and Leblond (14) found it also in the serum of
lactating mares. Geschickter and Lewis (15) found notable
quantities of prolactin in cystic human mammaries and in the
mammaries of post-partum cows. Leblond and Noble (16) find
traces in whole fish liver and brain, and Bates and Riddle
(unpublished) confirmed this result with pigeon liver. Part, but
not all, of these results were obtained by the extraordinarily
sensitive local crop-sac test of Lyons and Page (17); it is doubtful
whether a test equally as sensitive as this latter test is now
available for any other anterior pituitary product. Moreover,
the implantation of intact untreated pituitaries of pigeons
(Riddle and Schooley, 18), of fowl (Burrows and Byerly, 19) and
of rats (Reece and Turner, 20) has permitted the detection of
prolactin in all these untreated glands.
Follicle-stimulating hormone (FSH) is well known to be
present in large quantities in the serum of mares during most of
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the term of pregnancy (Cole and Hart, 21). Many studies have
indicated the presence of this hormone in human blood during
pregnancy, and after castration or the menopause. Again, the
implantation of intact untreated pituitaries of mice and rats—in
the classic experiments of Smith and Engle (22) and Zondek
and Aschheim (23)—supplied the original evidence that this
hormone exists in the pituitary.
Luteinizing hormone (LH) extracted from urine and placenta
seems to differ from that of pituitary origin. Hellbaum (24)
reports the isolation from mare serum of an LH which is similar
to pituitary LH. Again, the implantation of untreated pitui-
taries produced luteinization (22, 23)—though this alone does
not establish the existence of a luteinizing hormone of pituitary
origin.
Thyrotropic hormone apparently has not been satisfactorily
demonstrated in the blood—probably because a sufficiently
delicate test for minute amounts of it have not yet been devel-
oped. A few cc.of mare serum—very rich in FSH—were found
incapable of affecting the metabolic rate of doves (2). But
implantation of surviving anterior lobe to the vicinity of the
thyroid has supplied evidence of the capacity of such tissue to
stimulate the thyroids (Atwell, 25; Etkin, 26).
Other alleged pituitary hormones can not here be given a
similar individual survey. But we note our opinion that evidence
of the types (and in the volume) so easily cited for prolactin and
FSH is not available for the several alleged entities: growth,
adrenotropic, diabetogenic, ketogenic, fat metabolism, antag-
onist, interstitial cell stimulating, pancreatropic and para-
thyrotropic. It is true of course that less sensitive tests may
have interfered with positive findings in these cases. The
growth response in rats has indeed been obtained from untreated
rat (and pig) pituitary implants (Smith, 27; Smith and Dortz-
bach, 28); but on the point here in question that result is quite
indecisive since other data suggest that the growth response
rests upon the sum of helpful things contributed by more than
one pituitary hormone. Smith (27) was the first to show that
the thyroid hormone (desiccated thyroid), added to "growth"
hormone, could cause more rapid growth (hypophysectomized
rats) than did the growth extract alone.
Some at least of the above list of "alleged entities" almost
certainly rest upon the wholly unsubstantial basis that the
injection of a pituitary extract was followed by a particular
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response, this response thereafter gratuitously supplying a name
for an imagined product in the pituitary—whereas the response
may in fact rest upon (a) a hormone produced in any such organ
as the thryoid, gonad, adrenal, pancreas, liver, or indeed (b)
upon a combined action of hormones produced in several of
these organs; or, again (c), some responses thus translated into
entities may rest, in part at least, upon the contamination of
true anterior lobe hormone by effective amounts of intermedin
or posterior lobe hormones. Few things are easier than to find
a hitherto unrecognized response to the administration of mixed
pituitary extracts; and few things are more difficult than to
prove that the new response is produced by a hitherto unrecog-
nized specific anterior pituitary product.
It is against the background of the preceding discussion that,
for the present, it seems helpful and possible to think of two
groups of substances elaborated by the pituitary; and also
possible to associate the one group with the eosinophils and the
other with the basophils. Since cytological phenomena within
both these types of cells show waxing and waning aspects of the
process of hormone formation (secretion) it seems possible that
the effective molecules formed while the cell is being forced to
halt secretion is not the exact equivalent of that formed under
conditions which accelerate its secretory activity (thus recalling
the production successively of estrone and progesterone by the
same ovarian cell—or from a derivative of it). Though this
concept has no experimental basis it would permit us to ration-
alize the production of more than one (chemically related)
hormone in the same cell or type of cell. A gonadotropic chem-
ical relative (s) of FSH, or even thyrotropic hormone, might
thus arise from the basophil; again, perhaps prolactin-adreno-
tropin and thyrotropic might come from reverse phases of the
functioning of individual eosinophil cells—some of which are in
regressive phase at the moment others are highly active.
We here recall that though one is forced to speculate there
should be an end to it. It is now an observed fact that an element
(light) of the external environment (Rowan, 29) and the nervous
system (Friedgood and Pincus, 30; Haterius and Derbyshire,
31) both share in regulating the output of at least some pituitary
hormones (FSH). To this must be added important facts indi-
cating that the production of certain pituitary hormones is
affected by the output of other pituitary hormones or by sec-
ondary products of the action of a pituitary hormone. Thus a
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release of gonad-stimulating hormone leads to a stimulation of
sex-hormones (estrone, testosterone) and these usually so act
upon pituitary cells as to check or suppress the further release of
FSH (Moore and Price, 32; and others), while the estrone
induces a release of LH (Hohlweg, 33; Fevold, Hisaw and
Greep, 34). Again, it is reported (Bates, Riddle and Lahr, 35)
that prolactin (an eosinophilic product) is capable of suppressing
the release of FSH (a basophilic product) in mature birds.
These few instances of means of control of pituitary hormone
output have wide biological significance since they permit us
to begin to see the regulatory mechanism for some of the most
intricate aspects of biologic organization and adaptation.
SOME RESPONSES TO SPECIFIC HORMONES
We may now consider briefly certain results recently obtained
in our own laboratory which have bearing upon some of the
general views already discussed. We first examine some results
dealing with relationships of the prolactin-adrenotropin com-
ponent (of eosinophilic origin) to carbohydrate and fat metab-
olism and to growth.
Data of Riddle and Dotti (36; and unpublished) show that
in pigeons, doves and rabbits (apparently not in rats) the blood
sugar is increased by injecting these animals with prolactin.
Table I gives some typical findings on pigeons.
Most of the preparations used in these studies were in fact
called prolactin; but certainly some of those preparations (not
Nos. 380, 394H) had power to enlarge the adrenals of 21-day
old rats or partially to repair the adrenal cortex of hypophy-
sectomized pigeons. These cortical responses have been assigned
to a separate substance—corticotropin—by Collip, Anderson
and Thomson (37), Anselmino, Hoffman and Herold (38),
Lyons (39) and Moon (40). At the moment we can exclude
corticotropin or " adrenotropin" as a causative agent for the
tabulated changes in blood sugar, though its presence does
affect glycogen storage as noted below. We can also exclude
such substances as intermedin, posterior lobe hormones,
FSH, LH and thyrotropic hormone as the effective agents.
Many of the effective preparations were first subjected to heat
(boiling for 1 hour, or 60° C. for 5 hours).
Other data (Johnson and Riddle, unpublished) show that
some of these same prolactin preparations also markedly


















Excerpt from data of Riddle and Dotti. Action of prolactin (3 tests of adrenotropin at bottom)
on blood sugar in pigeons fasted 20-24 hours.






































*As prepared by method of Lyons (39) and Moon (40) by Dr. R. W. Bates; 10 mgm. daily in all tests, and containing the amount
of prolactin indicated.
For performing, and checking the completeness of the various operations on animals utilized here, we are indebted to Dr. J. P.
Schooley of our laboratory.
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the livers of normal and hypophysectomized birds. This
response followed the use of prolactin preparations with which
we could demonstrate no enlargement of the 21-day rat adrenal,
though it was evidently more pronounced when preparations
having capacity to enlarge such adrenals were used. This
result, however, was not further increased by the use of all the
hormones contained in a whole extract of the pituitary. It
seems that both prolactin and adrenotropin share in one phase
of carbohydrate mobilization and utilization; other available
evidence (41) points to rapid enlargement of livers (also intestine
and pancreas) as a true prolactin response.
Still other data (Johnson and Riddle, unpublished) clearly
indicate that prolactin (adrenotropic?) also increases the fat
content of these bird livers (which are simultaneously both
enlarging and increasing their glycogen content). This increase
of liver fat (in hypophysectomized pigeons) can apparently be
somewhat emphasized by the adrenotropin element of whole
pituitary extracts. Possibly bearing on this point is the observa-
tion that, in normal doves, the injection of estrone increases the
amount of fat in the liver. This ovarian hormone had no
apparent effect upon hepatic glycogen.
From the above one gets indications that responses traceable
to the prolactin-adrenotropin complex—at one point (liver fat)
associated with action of a secondary product of the FSH com-
plex—may encompass or include responses attributed to such
additional "entities" as diabetogenic, ketogenic, and fat
metabolism (and pancreatropic?).
Further consideration of prolactin, or possibly of the
prolactin-adrenotropin complex, will indicate that in pigeons it
too is responsible for splanchnomegaly—hitherto considered an
aspect of the growth response and ascribable to a "growth"
hormone. The data of Table 2 show that body growth, with
rapid and excessive increase of liver weight, is obtained in
Carneau pigeons by the administration of relatively highly
purified preparations of prolactin. At three weeks after hatching
the rapidly growing young pigeon shows crop-gland stimulation
from prolactin produced in its own pituitary; and at this stage
it shows—in addition to an amazing rate of body growth—
relative overgrowth in liver, intestines, and probably in the
pancreas. When similar birds were somewhat older, and in
growth stasis, the administration of prolactin was followed by a












Excerpt from data of Bates, Riddle, Lahr and Schooley (41). Aspects of splanchnomegaly associated with the phase of rapid growth
(1.3 months) in uninjected young White Carneau Pigeons and in similar young (2.2 mo.) injected for four days with
prolactin. The standard deviation of the mean is given with each averaged value.
ROUTE OF NO. OF AGE DAILY BODY LIVER









Uninjected; youngest (1.3 mo.) group in extremely rapid growth.






Injected with iso-insoluble fraction No. 469=prolac tin.
"Intramuscular (5) and subcutaneous (5).
1Gain or loss of weight is indicated for all injected birds.
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intestines (still other data obtained with Drs. Schooley, Lahr
and Bates show this for the pancreas, and show that these
aspects of body growth and visceral overgrowth are likewise
obtained in hypophysectomized pigeons). Administration of an
isosoluble pituitary preparation, known to be rich in FSH and
thyrotropic hormones and probably containing all anterior lobe
hormones except prolactin, produced none of these effects.
Though the above-described splanchnomegaly has not been
induced in the rat, by the same preparations of prolactin which
TABLE III
Excerpt from data of Riddle and Dotti. Effect of cortin (Kendall) on blood



























































































*Dose divided (twice daily).
1Intraperitoneal injection.
2Cortin inactivated by heat (96° C , 2 hrs.) used here.
produce it in doves and pigeons, positive results are regularly
obtained in these latter species. The allocation to prolactin (or
to heated prolactin-adrenotropin preparations) of these aspects
of growth and overgrowth in these species provides a basis for
further doubt as to the separateness or singleness of a "growth"
hormone in the pituitary.
Returning now to the r61e of the adrenal cortex in carbo-
hydrate metabolism one first notes that Long and Lukens (see
Long, 42) have shown that glycosuria is produced in cats and
rats by the effective pituitary hormone (or hormones) in the
absence of both the pancreas and the hypophysis, but not in the


















Excerpt from data of Riddle and Dotti. Effect of pituitary (top) and of sex hormones (below) on serum calcium.
DOSAGE ANIMALS USED SERUM CALCIUM
PREPARATION OF HORMONE (mgm. per 100 cc.)
Quantity Daily Term No. Kind
cc. or units days
Whole A. P. extr. (all A. P. hormones)..... 0.3 cc. 3 6 O71 9 Hypct. juv. pigeons
Prolactin 15.0 d. u. 10 10 C71 9 Hypct. juv. pigeons
FSH (+LH?) Mare serum 0.4 cc. 9 13 o71 9 Hyp. adult pigeons
FSH (4-LH?) Mare serum 1.0 cc. 6 2 9 Partial, adrenalect., ad.
FSH+thyrotropic (from A. P.) 2 mg. 5 2 9 Thyroidectomy, ad
Estrone 250 R. U. 6 7 o719 Normal juv. pigeons
" 200 R. U. 7 2 c? Hypct. pigeons, ad
3000 R. U. 2 2 9 Dogs
" 3000 R. U. 8 3 9 Rabbits
Dihydroestrone 1000 R. U. 3 3 9 Non-laying hens
" 200 R. U. 6 2 o71 Part, hypct. ad. pigeons
" 375 R.U. 7 3 cf 9 Castrate rats
Progesterone 1 Rb. U. 3 2 o71 Normal pigeon, ad
« 0.1 Rb. U. 10 2 9 Normal rats
Testosterone 2.5 mgm. 7 2 cf Hypct. pigeon, ad
" 2.0 mgm. 7 4 c? 9 Normal pigeons, ad
" 5.0 mgm. 3 3 c? 9 Rabbits
Androstendiol 3.5 C. U. 7 2 d1 9 Hypct. pigeons, ad
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prolactin (probably with some adrenal-stimulating power) pre-
pared in our laboratory and also adrenotropin (probably con-
taining prolactin) prepared by Collip were both very effective
in the production of glycosuria in animals with intact adrenals.
Houssay and Leloir (43), however, do not regard the adrenals as
necessary to this response in toads and dogs. Britton (44) has
long maintained that cortin (adrenal cortical hormone) raises
the blood sugar of the mammalian species studied by him. The
data cited below support Britton's views and extend the
observations to birds.
In Table 3 are given some data of Riddle and Dotti (36, and
unpublished) showing that in doves and pigeons cortin increases
the blood sugar during the first several hours after injection but
that this effect disappears within less than 23 hours. Of course
the pituitary hormone which stimulates the cortex would pro-
vide for a continuous secretion of cortin and thus for its conti-
nuity of action on the blood sugar. We are much indebted to
Dr. E. C. Kendall, Mayo Clinic, for the cortin used in the
tabulated tests. Cortin kindly supplied by Dr. David Klein,
The Wilson Laboratories, and Dr. R. L. Zwemer, Columbia
University, gave similar results.
These several items indicate that the diabetogenic response
is, in part at least, mediated through other incretory glands, and
that cortin possibly shares in this response. Cortin—as shown
by the work of Hartman, of this University, and by others—
contributes so much to the well-being of the organism that it is
difficult to conceive its exclusion from the growth response, and
particularly to that response in hypophysectomized animals.
Again, Hitchcock and Grubbs (45) recently report that the
administration of cortical extract to normal human beings tends
to increase their muscular efficiency during light work; and this
sparing of heat production may have significance in the growth
process. Finally, it is not improbable that the adrenal cortex
produces still other hormones than cortin, and that hitherto
their effects may have helped to swell the number of products
supposedly produced in the pituitary gland.
We conclude this discussion with a very brief consideration
of a response obtained with an FSH component (of basophilic
origin), and with the secondary products (sex hormones) of
its action on the gonads. Originally this study was directed to
an examination of the evidence for the production by the
anterior pituitary of a special "parathyrotropic" hormone—a
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hormone alleged to stimulate the parathyroid glands to an
increased production of parathormone, which in turn is known
to increase the blood calcium.
In this study (Riddle and Dotti, 46; and unpublished data)
it was soon found that prolactin and cortin were without effect,
but the injection (prolonged and adequate dosage) of the FSH
component into suitable animals resulted in increased amounts
of calcium in the blood serum. Whole pituitary extracts gave a
like result. The serum from pregnant mares, with FSH as the
sole probably active factor, is effective. Later it was found that
the female sex hormones have this power, and that male sex
hormones have little or no similar action. Typical results are
given in Table 4. We are greatly indebted to Dr. Erwin
Schwenk, of the Schering Corporation, for the sex hormones
used in that study.
Though it is uncertain whether or to what extent the
parathyroids share in the response (castration prevents it) to
FSH it is evident that the calcium elevating property of the
sex hormones is exercised in the absence of either hypophysis,
gonads, thyroids, and probably the parathyroids. It is also
evident that before one can accept " parathyrotropic " pituitary
hormone as an entity these new facts concerning the r61e of
FSH and sex hormone must be concurrently examined.
On this day of continuous flux—along with gratifying
advance—in all that pertains to the hormones of the anterior
pituitary one may be neither too positive nor profitably attempt
to be encyclopedic. In the present effort we have ventured—
and have exposed all flanks in stating a point of view which we
hope may be of momentary service. A little, but much too
little, of the documentation of new research has indicated a part
of the basis for an opinion that few true anterior pituitary hor-
mones exist; that a greater variety of unfinished pituitary
products exist; that secondary products of pituitary hormone
action in other glands may have been mistaken for primary
pituitary products; and that the true anterior pituitary hor-
mones perhaps arrange themselves in two groups.
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